- Home
- ROIV vs VOYA Comparison
ROIV vs VOYA Comparison
Compare ROIV & VOYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- VOYA
- Stock Information
- Founded
- ROIV 2014
- VOYA 1975
- Country
- ROIV United Kingdom
- VOYA United States
- Employees
- ROIV N/A
- VOYA N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- VOYA Life Insurance
- Sector
- ROIV Health Care
- VOYA Finance
- Exchange
- ROIV Nasdaq
- VOYA Nasdaq
- Market Cap
- ROIV 8.6B
- VOYA 7.4B
- IPO Year
- ROIV N/A
- VOYA 2013
- Fundamental
- Price
- ROIV $16.17
- VOYA $75.08
- Analyst Decision
- ROIV Strong Buy
- VOYA Buy
- Analyst Count
- ROIV 8
- VOYA 12
- Target Price
- ROIV $19.94
- VOYA $83.17
- AVG Volume (30 Days)
- ROIV 9.5M
- VOYA 710.9K
- Earning Date
- ROIV 11-11-2025
- VOYA 11-04-2025
- Dividend Yield
- ROIV N/A
- VOYA 2.40%
- EPS Growth
- ROIV N/A
- VOYA N/A
- EPS
- ROIV N/A
- VOYA 5.01
- Revenue
- ROIV $23,233,000.00
- VOYA $7,916,000,000.00
- Revenue This Year
- ROIV N/A
- VOYA N/A
- Revenue Next Year
- ROIV $248.22
- VOYA $3.59
- P/E Ratio
- ROIV N/A
- VOYA $15.00
- Revenue Growth
- ROIV N/A
- VOYA 2.46
- 52 Week Low
- ROIV $8.73
- VOYA $52.43
- 52 Week High
- ROIV $16.19
- VOYA $84.30
- Technical
- Relative Strength Index (RSI)
- ROIV 80.34
- VOYA 48.90
- Support Level
- ROIV $14.86
- VOYA $73.61
- Resistance Level
- ROIV $16.15
- VOYA $76.65
- Average True Range (ATR)
- ROIV 0.43
- VOYA 1.40
- MACD
- ROIV 0.06
- VOYA -0.30
- Stochastic Oscillator
- ROIV 99.12
- VOYA 36.12
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About VOYA Voya Financial Inc.
Voya Financial Inc is a financial services company, which, through its subsidiaries, provides various investment, insurance, and retirement solutions to individual and institutional clients in the United States. Its products and services include tax savings plans, individual retirement accounts, group life insurance plans, and employee benefits products, among others. The company tailors each of its products to the needs of its customer base. It operates its business through three principal lines: Wealth Solutions, Investment Management, and Health Solutions The Wealth segment generates roughly half of the company's revenue.